Clinical-stage biotech developing virus-like drug conjugates (VDCs) for solid tumors, focusing on ocular and urologic cancers.
Get notified the moment Aura Biosciences, Inc. (AURA) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.